Farrukh Ameer Mustafa, Ganipineni Vijaya Durga Pradeep, Jindal Urmi, Chaudhary Abhishek, Puar Ravinderjeet Kaur, Ghazarian Klodin, Corrales Vanessa Vidaurre, Alarcón Sandy Escobar, Remala Kavya, Thota Naganath, Vijayan Shivahari, Rathore Sawai Singh
University of Galway School of Medicine, Galway, Ireland.
Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
Curr Probl Cardiol. 2024 Jan;49(1 Pt A):102029. doi: 10.1016/j.cpcardiol.2023.102029. Epub 2023 Aug 9.
This meta-analysis aims to systematically review and analyze available studies on the association between myocarditis and dengue viral fever. A comprehensive literature search was carried out using several databases. Mantel-Haenszel odds ratios and associated 95% confidence intervals were produced to report the overall effect size using random effect models. Besides, random effects models were used to calculate the overall pooled prevalence. Data from 26 articles (6622 dengue patients) showed that pooled estimate of myocarditis in dengue fever was 12.4% (95% CI, 8.41-17.08). Higher prevalence was seen in reports from Asia (15.2%) compared to that from Latin America (3.6%). Besides, the pooled prevalence of severity and mortality was 34% (95% CI, 20.49-49.04) and 26.44% (95% CI, 18.07-35.78) respectively. Significantly higher prevalence rates of severe disease in the pediatric population (52.4%) and studies with a higher percentage of females (52.1%) were also observed. However, higher mortality rates were seen in the adult population (34.8%) compared with the pediatric age group. Further, myocarditis in dengue patients was associated with increased risk of severity (RR = 2.44, 95% CI 1.007-5.93, P = 0.048) and mortality (RR = 19.41, 95% CI 7.19-52.38, P < 0.001) compared with dengue patients without myocarditis. No significant publication bias was evident in the meta-analysis. The findings highlight the clinical significance of early identification and management of myocarditis in patients with dengue fever.
这项荟萃分析旨在系统回顾和分析关于心肌炎与登革热病毒热之间关联的现有研究。使用多个数据库进行了全面的文献检索。采用随机效应模型生成Mantel-Haenszel优势比及相关的95%置信区间,以报告总体效应大小。此外,使用随机效应模型计算总体合并患病率。来自26篇文章(6622例登革热患者)的数据显示,登革热患者心肌炎的合并估计患病率为12.4%(95%置信区间,8.41 - 17.08)。与拉丁美洲(3.6%)的报告相比,亚洲报告中的患病率更高(15.2%)。此外,严重程度和死亡率的合并患病率分别为34%(95%置信区间,20.49 - 49.04)和26.44%(95%置信区间,18.07 - 35.78)。在儿科人群(52.4%)和女性比例较高的研究(52.1%)中,也观察到严重疾病的患病率显著更高。然而,与儿科年龄组相比,成人人群的死亡率更高(34.8%)。此外,与无心肌炎的登革热患者相比,登革热患者的心肌炎与严重程度增加的风险(相对风险 = 2.44,95%置信区间1.007 - 5.93,P = 0.048)和死亡率增加的风险(相对风险 = 19.41,95%置信区间7.19 - 52.38,P < 0.001)相关。荟萃分析中未发现明显的发表偏倚。这些发现突出了登革热患者心肌炎早期识别和管理的临床意义。